Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. by Wilson, A. et al.
 J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2001/10/1003/10 $5.00
Volume 194, Number 7, October 1, 2001 1003–1012
http://www.jem.org/cgi/content/full/194/7/1003
 
1003
 
Notch 1–deficient Common Lymphoid Precursors Adopt a
B Cell Fate in the Thymus
 
Anne Wilson, H. Robson MacDonald, and Freddy Radtke
 
Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne,
1066 Epalinges, Switzerland
 
Abstract
 
We have recently reported that Notch 1, a member of the Notch multigene family, is essential
for the development of murine T cells. Using a mouse model in which Notch 1 is inactivated
in bone marrow (BM) precursors we have shown that B cells instead of T cells are found in the
thymus of BM chimeras. However, it is not clear whether these B cells develop by default from
a common lymphoid precursor due to the absence of Notch 1 signaling, or whether they arise
as a result of perturbed migration of BM-derived B cells and/or altered homeostasis of normal
resident thymic B cells.
In this report we show that Notch 1–deficient thymic B cells resemble BM B cells in pheno-
type and turnover kinetics and are located predominantly in the medulla and corticomedullary
junction. Peripheral blood lymphocyte analysis shows no evidence of recirculating Notch1
 

 
/
 

 
BM B cells. Furthermore, lack of T cell development is not due to a failure of Notch1
 

 
/
 

 
 pre-
cursors to home to the thymus, as even after intrathymic reconstitution with BM cells, B cells
instead of T cells develop from Notch 1–deficient precursors. Taken together, these results
provide evidence for de novo ectopic B cell development in the thymus, and support the hy-
pothesis that in the absence of Notch 1 common lymphoid precursors adopt the default cell
fate and develop into B cells instead.
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Introduction
 
Notch proteins have been shown to play crucial roles in bi-
nary cell fate decisions in many developmental systems (1).
In mammals, four Notch receptors and five transmembrane
bound ligands have been identified to date (1–3). Several
reports have suggested a role for Notch family members in
T cell development (for reviews, see references 4–7).
Notch 1, 2, and 3 as well as the ligands Jagged 1 and 2 have
been shown to be expressed in thymocytes and thymic
stromal epithelium (5, 8). We have recently described mice
in which the loxP flanked Notch 1 gene was inactivated in
an inducible manner by means of a Cre-recombinase trans-
gene under the control of an IFN-
 

 
 responsive promoter
(9). By reconstituting irradiated mice with a mixture of
control and Notch 1
 

 
/
 

 
 bone marrow (BM)
 
*
 
 we showed
that the Notch1 receptor is essential for the development of
all conventional T cells in the thymus as well as for the thy-
mus independent intestinal intraepithelial lymphocyte sub-
set (9–11). Instead of T cells, immature B cells of Notch
1
 

 
/
 

 
 origin accumulated in the thymus of such BM chime-
ras. By analogy with the role of Notch genes in inverte-
brate systems one interpretation of these data is that Notch
1 provides a critical inductive signal that directs a bipoten-
tial T/B precursor toward a T cell fate. In the absence of
Notch 1 signaling, bipotential precursors would develop
into immature B cells in the thymus as a default pathway.
Alternatively, the T cell deficiency observed in Notch 1
 

 
/
 

 
BM chimeras might reflect a failure of lymphoid precursors
to home from the BM to the thymus. According to this
scenario the accumulation of immature B cells of Notch
1
 

 
/
 

 
 origin in the thymus would be unrelated to lineage
commitment and might reflect either pertubated migration
of immature B cells from the BM to the thymus or in-
creased proliferation of resident intrathymic B cells.
The presence of a small number of B cells (0.1–0.2% of
total thymic cells), in both the human and murine thymus
has been known for some time (12, 13). Resident thymic B
cells have a predominantly mature or activated phenotype
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(summarized in reference 14), and are principally located in
clusters at the corticomedullary junction or in the medulla
(13, 15). Several recent reports have demonstrated the pres-
ence of putative B cell progenitors (and hence limited B
cell development) in the thymus (16, 17), and have further
suggested that thymic B cells may even migrate out to pe-
ripheral lymphoid organs (17). In addition, an apparently
increased frequency of thymic B cells has been reported in
several T cell–deficient mouse models including the
TCR
 

 

 
/
 

 
 mutant (17, 18), and a transgenic mouse over-
expressing a human CD3
 

 
 transgene (CD3
 

 
26tg) at high
copy number (19, 20). By analogy with these models it is
possible that increased accumulation of B cells in the thy-
mus of Notch 1
 

 
/
 

 
 mice reflects increased B cell lym-
phopoiesis as a nonspecific consequence of altered T cell
development.
In an attempt to distinguish between these various possi-
bilities we have undertaken a detailed analysis of thymic B
cells derived from Notch 1–deficient BM precursors. Our
data indicate that these Notch 1
 

 
/
 

 
 thymic B cells resemble
BM B cells rather than mature peripheral B cells or normal
resident thymic B cells in terms of phenotype and turnover
kinetics. Moreover, immature Notch 1
 

 
/
 

 
 B cells are not
detectable in the circulation and can be generated (in the
absence of T cells) upon intrathymic injection of Notch
1
 

 
/
 

 
 BM precursors. Collectively our data demonstrate
that Notch 1
 

 
/
 

 
 immature thymic B cells arise in situ and
strongly suggest that they develop from bipotential T/B
precursors in the absence of inductive Notch 1 signaling.
 
Materials and Methods
 
Mice and Cell Suspensions.
 
Notch 1
 
lox/lox
 
 (control) and Notch
1
 
lox/lox
 

 
Mx-Cre
 
 (Notch 1 deleted) mice were generated as described
previously (9) and used at 8–12 wk of age. These mice are posi-
tive for the common leukocyte antigen CD45.2. Activation of
the Cre-recombinase was performed as described previously (9,
10). In brief, both Notch 1
 
lox/lox
 
 and Notch 1
 
lox/lox
 

 
Mx-Cre
 
 adult
mice received four intraperitoneal injections of 250 
 

 
g polyI–
polyC (pIpC; Sigma-Aldrich) at 2-d intervals. For BM chimeras
the mice were killed and the BM prepared for transplantation by
T cell depletion 2 d after the last injection. To quantitate deletion
of the Notch 1 gene, genomic DNA was prepared from a portion
of the T cell–depleted BM cells and deletion efficiency was veri-
fied by Southern blot analysis followed by PhosphorImager quan-
titation. To follow the kinetics of deletion of Notch 1 in adult
mice, both Notch 1
 
lox/lox
 
 and Notch 1
 
lox/lox
 

 
Mx-Cre
 
 mice were in-
jected with pIpC as described above, and killed for analysis at 7,
14, 21, or 28 d after the last injection.
CD45.1
 

 
 C57BL/6 congenic mice were purchased from The
Jackson Laboratory, and maintained on antibiotic containing wa-
ter after lethal (1,000 rads) or sublethal (550 rads) irradiation as
described previously (9). TCR
 

 

 
/
 

 
 mice were purchased from
The Jackson Laboratory and the CD3
 

 
26 tg (19) mice were the
gift of Dr. Georg Holländer, Kantonspital, Basel, Switzerland.
Thymocyte, BM, spleen, and LN cell suspensions were prepared
and stained for FACS
 
®
 
 by standard procedures. PBLs were pre-
pared by collecting several drops of blood from the tail vein into a
tube containing two drops Heparin to prevent clotting. After di-
luting to 1 ml in PBS, the suspension was underlayed with 1 ml
 
Lymphoprep M (Cedarlane Laboratories) and centrifuged for 15
min at room temperature at 700 
 
g
 
. Lymphocytes were collected
from the interface, washed in PBS, and stained for FACS
 
®
 
 fol-
lowing standard proceedures.
 
FACS
 
®
 
 Analysis and Monoclonal Antibody Conjugates.
 
Four
color flow cytometric analysis was performed as described previ-
ously (9, 11). The following monoclonal antibodies were pur-
chased from BD PharMingen: CD45.1-FITC and –biotin (clone
A20); CD45.2-FITC, and –biotin (clone 104); CD4-CyChrome
(clone RM4–5), CD19-FITC (clone 1D3), BP-1-PE (clone
6C3), class II (anti-IA
 
b
 
)-PE (clone M5/114.15.2), Sca-1-FITC
(clone D7), and CD43-FITC (clone S7). AA4.1-biotin (clone
493) was the gift of Dr. Antonius Rolink, Basel Institute for Im-
munology, Basel, Switzerland and IgM (a
 

 
b)-biotin (50:50 mix-
ture of RS1.3 and MB 86) was the gift of Dr. Hans Acha-Orbea,
Ludwig Institute for Cancer Research, Lausanne, Switzerland.
CD8
 

 
-Cy5, CD25-Cy5, CD45.1-Cy5, and CD45.2-Cy5 were
purified from hybridoma supernatants (clones 53.6.7, PC61,
A20.1, and 104, respectively) and conjugated in this laboratory
using Cy-5 (Amersham Pharmacia Biotech). CD45.2-PE (clone
A20) was conjugated in this laboratory using purified protein
purchased from BD PharMingen and the PE conjugation kit
(Prozyme). Biotinylated antibodies were revealed with Streptavi-
din-PE (Caltag), Streptavidin-CyChrome (BD PharMingen), or
Streptavidin-allophycocyanin (APC) (Molecular Probes) conju-
gates. FACS
 
®
 
 analysis was performed on a FACSCalibur™ flow
cytometer (Becton Dickinson), and data analysis using CELL-
Quest™ software (Becton Dickinson).
 
Intrathymic Injection and BM Chimeras.
 
Intrathymic injections
were performed as described (21–23). Briefly, CD45.1
 

 
 C57BL/6
congenic female mice were sublethally irradiated (550 rads)
then anaethestized with a mixture of Ketamine hydrochloride
(1.2 mg/100 g body weight) (Ketaset; Bristol Myers Co.) and
Dormicom (0.12 mg/100 g body weight), a muscle relaxant, in-
jected intraperitoneally. After verifying that they were adequately
anethestized, the skin over the lower cervical and upper thoracic
region was cut and pulled aside to reveal the chest wall. The up-
per third of the sternum was bisected longitudinally to reveal the
thymus and the left thymic lobe injected with 10 
 

 
l of PBS con-
taining 10
 
6
 
 total BM cells using a 100 
 

 
l Hamilton syringe
equipped with a 30G needle and mounted on a Chaney adaptor
(Polylabo SA.) to control the volume delivered. The chest wall
and skin were closed with surgical wound clips to maintain tho-
racic pressure. The mouse was gently warmed under an infrared
lamp until the effects of the anesthetic wore off. Mice were main-
tained on antibiotic containing water until killed for analysis be-
tween 21 and 24 d later.
Individual thymic lobes were analyzed for the contribution of
donor or host cells to reconstitution by staining with antibodies
to CD45.2 and CD45.1, respectively. The phenotype of
CD45.2
 

 
 donor derived cells was further analyzed by FACS
 
®
 
with antibodies directed against T cell (CD4, CD8, TCR
 

 
), and
B cell (B220, IgM and AA4.1) specific markers. Mixed BM chi-
meras were prepared as described previously (9, 10) and analyzed
2–3 mo after reconstitution.
 
Bromodeoxyuridine Uptake to Assess Cell Turnover Rate.
 
Mice
were injected intraperitoneally with a single dose (180 
 

 
g) of
bromodeoxyuridine (BrdU; Sigma-Aldrich) at the time points in-
dicated, then fed continuously with water containing 800
 

 
g/ml
BrdU and 5% glucose. Surface staining for FACS
 
®
 
 was performed
as described above using PE-, CyChrome-, Cy5-, APC-, or bio-
tin-conjugated antibodies. Fixation, permeabilization, DNase
treatment, and intracellular staining with anti–Brdu-FITC anti-
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body was performed using the BrdU labeling kit (BD PharMin-
gen). Cells stained in the same manner but isolated from an unin-
jected mouse were used in all cases as negative controls for BrdU
staining. Percent BrdU uptake for each population was measured
from at least five individual experiments and results are expressed
as mean 
 

 
 SD.
 
Results
 
Accumulation of Immature B Cells in the Thymus of Notch
1–deficient Mice.
 
In a previous study (9) we have shown that
inducible inactivation of Notch 1 in the BM (with an
IFN-
 

 
–responsive Mx-Cre transgene) results in a com-
plete block in T cell development. Instead of T cells, im-
mature B cells of Notch 1–deficient origin are found in
the thymus. These findings clearly showed that expression
of the Notch 1 protein is essential in early T cell lineage
commitment and suggested that lymphocyte precursors
adopt a B cell fate in the thymus in the absence of Notch
1 signals. All of the above data were generated in a mixed
BM chimera system which requires large numbers of mice
and a long period to establish stable chimerism. To facili-
tate further studies we have used an adult deletion model
in which 4–8-wk-old adult mice carrying the floxed
Notch 1 gene together with (Notch 1
 

 
/
 

 
), or without
(control) the Mx-Cre transgene are treated with pIpC. In
Mx-Cre–positive mice the floxed Notch 1 gene is deleted
while in control mice the gene is left intact due to the ab-
sence of the Cre-recombinase. Although deletion in dif-
ferent organs is of variable efficiency, it is close to 100%
in the BM (9). As the vast majority of immature thy-
mocytes are generated from incoming BM precursors
over a short period of time (10–14 d; reference 24), we
are now able to analyze the effects of Notch 1 deletion on
intrathymic T cell development. In addition, this system
also allows a more detailed analysis of the rate of appear-
ance and phenotype of the immature B cell population in
the thymus.
As shown in Fig. 1 A, the total number of thymocytes
rapidly decreases over 4 wk (138 
 

 
 23 
 
	
 
 10
 
6
 
 down to 10 
 

 
5 
 
	
 
 10
 
6
 
), with a concomitant increase in the percentage
of double-negative (DN) thymocytes from 2% of total thy-
mus in control pIpC-treated mice (21 d after deletion) to
31% in the thymus of Notch 1–deleted mice after 28 d. In
agreement with the mixed BM chimera studies performed
previously, this DN population is largely composed of
CD19
 

 
B220
 

 
 B cells. This Notch 1–deficient B cell popu-
lation increases in total number from 0.24 
 

 
 0.13 
 
	
 
 10
 
6
 
per thymus to between 2 and 6 
 
	
 
 10
 
6
 
 (3.6 
 

 
 1.6), so that
by 28 d after deletion it comprises 
 

 
85% of the DN thy-
mus subset. Furthermore, a significant percentage of these
Notch 1–deficient B cells express lower levels of B220 and
CD19 consistent with their immature phenotype.
Fig. 1 B shows a comparison of BM B cells and B cells
found in the thymus of Notch 1–deficient mice 28 d after
deletion. The staining patterns for B220 versus IgM and
B220 versus CD43 on BM and Notch 1–deficient thymus
look very similar suggesting that B lineage cells of equiva-
 
lent differentiation status are present in both the BM and
the thymus in the absence of Notch 1.
 
Four-Color FACS
 
®
 
 Analysis Was Used to Investigate in De-
tail the Phenotype of Thymic Notch 1–deficient B Cells Com-
pared with BM B Cells and Peripheral LN B Cells.
 
Fig. 1 C
shows a comparison of thymic B cells found in both the
mixed BM chimeras and in the adult deletion model (21 d
after deletion) together with the pattern of expression of
the same markers on LN or BM B cells. Notch 1–deficient
thymic B cells obtained from either mixed BM chimeras
or adult deleted mice show heterogeneous surface expres-
sion of the mature B cell markers IgM, IgD, and Sca-1
similar to BM B cells and in contrast to LN B cells. Fur-
thermore, Notch 1–deficient thymic B cells are also heter-
ogeneous for expression of the immature B cell markers,
AA4.1, BP-1, and CD25 which are normally not ex-
pressed by mature LN B cells but have heterogeneous ex-
pression patterns on BM B cells.
 
Notch 1–deficient B Cells Increase in Number in the Thymus
Concomitant with a Loss of T Cell Precursors.
 
During adult
life the thymus is continually seeded by CD44
 

 
117
 

 
Sca-1
 

 
 lin-negative lymphocyte precursors entering from
the BM. Once in the thymus these precursors undergo a
series of phenotypic changes characterized by transient ex-
pression of CD25 and loss of CD44 and CD117. Thus,
early DN precursors progress through sequential CD44
 
hi
 
CD25
 

 
CD117
 
hi
 
 (DN 1), CD44
 
hi
 
CD25
 

 
CD117
 
hi
 
 (DN 2),
CD44
 
lo
 
CD25
 

 
CD117
 

 
 (DN 3), and CD44
 
lo
 
CD25
 

 
CD117
 

 
 (DN 4) stages (25). As shown in Fig. 2, the
number of DN 1, DN 2, and DN 3 thymocytes decreases
rapidly following deletion of Notch 1, consistent with a
complete block in T cell development from a BM precur-
sor cell. As expected, the kinetics of disappearance of DN 1
and DN 2 precursors is faster than that of the DN 3 sub-
set in Notch 1–deficient mice (Fig. 2), consistent with
their earlier appearance and disappearance during normal
thymus development. By day 28 after deletion there are
virtually no identifiable thymic precursor cells. Interest-
ingly, this progressive loss of Notch 1
 

 
/
 

 
 T cell precur-
sors is mirrored by a concomitant increase in B cells in
the thymus. In contrast, there is no change in the num-
ber of resident thymic B cells nor in any of the DN pre-
cursor subsets in control mice treated with pIpC (data
not shown).
 
Immature B Cells Are Not Recirculating from the BM to the
Thymus in Notch 1–deficient Mice.
 
One simple explana-
tion for the apparent accumulation of immature B cells
in the thymus of Notch 1–deficient mice could be that
treatment with pIpC to induce the IFN-
 

 
 required to
activate Cre-recombinase–mediated deletion of Notch 1
induces a wave of migration of immature B cells from
the BM to the thymus. If this were the case, a large
number of immature B cells would be detectable in the
peripheral blood of pIpC-treated mice. To rule out this
possibility, PBLs from Notch 1–deficient and control
mice were analyzed for the presence of immature B cells
by FACS
 
® 
 
at various times between 2 and 28 d after de-
letion.
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Only mature phenotype B cells were detected in the
blood of both control and Notch 1–deficient mice during
this time period (Fig. 3, A and B, and data not shown).
This result shows that no aberrant recirculation of imma-
ture B cells is detectable after pIpC treatment.
 
Notch 1–deficient Thymic B Cells Are Turning Over at a
Similar Rate to BM B Cells and Not Peripheral B Cells.
 
Immature BM B cells are turning over rapidly while resting
mature B cells in the peripheral lymphoid organs are not
dividing. To determine if the immature B cells accumulat-
Figure 1. Kinetics of emergence of immature B
cells in the adult thymus after Notch 1 deletion. (A)
Total thymocyte numbers (	106) and the CD4
versus CD8 profiles (top row) of adult thymi from
control (left panel), Notch 1 deleted at 7, 14, 21,
and 28 d (respectively) after pIpC injection (middle
panels), compared with the profile obtained from
CD45.2 cells derived from Notch 1–deficient BM
in the mixed BM chimera system (right panel) after
3 mo. The relative percentage of DN thymocytes is
shown for each time point as well as the CD19 ver-
sus B220 FACS® analysis on gated DNs (bottom
row). Contour plots are representative examples of
individual mice. Data are mean  SD from 8–12
mice for each time point. (B) Expression of B220
versus IgM or CD43 on total BM and thymus from
Notch 1–deficient mice 28 d after deletion. (C) Ex-
pression of B cell markers, IgM, IgD, Sca-1, AA4.1,
BP-1, and CD25 on gated LN, BM, or thymic B
cells (gated on B220CD19) in CD45.2 Notch
1–deficient BM-derived cells from mixed BM chi-
meras compared with Notch 1–deficient thymic B
cells in the adult deletion model.
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ing in the thymus of Notch 1–deficient mice are in fact un-
dergoing de novo development in situ. Notch 1–deleted
mice were injected with a single dose of BrdU and subse-
quently fed BrdU in their drinking water for various times.
Cells that have divided during the period of BrdU adminis-
tration are specifically detected by intranuclear FACS®
staining with FITC-conjugated anti-BrdU antibodies to-
gether with surface staining to identify specific subpopula-
tions. As shown in Fig. 4, peripheral B cells (PBL and
spleen) from both control and Notch 1–deleted mice show
very little BrdU uptake over a 48-h period consistent with
their resting status. In contrast, a 20-fold increase in BrdU
labeling kinetics is observed in BM B cells from both con-
trol or Notch 1–deleted mice. While normal resident thy-
mic B cells in control mice have slightly faster BrdU label-
ing kinetics than resting mature B cells, Notch 1–deficient
thymic B cells label with BrdU 30-fold more rapidly. In-
deed, the BrdU labeling curve of Notch 1–deficient thymic
B cells is almost overlapping with that of BM B cells from
either control or Notch 1–deficient mice.
Notch 1–deficient BM Precursors Produce Immature B Cells
Instead of T Cells after Intrathymic Injection. To formally
rule out the possibility that the lack of T cell development
in the thymus is due to a failure of Notch 1–deficient BM
derived precursor cells to home to the thymus, Notch 1/
or control BM cells were injected directly into one lobe of
the thymus of sublethally irradiated CD45.1 congenic
mice. Approximately 3 wk after injection the thymi were
analyzed for the presence of donor-derived cells. As shown
in Fig. 5 A, a population of CD45.2 cells derived from
control or Notch 1–deficient BM can be detected in the
Figure 2. Concomitant increase in thymic B cells and decrease in DN
1, 2, or 3 immature thymocytes in adult Notch 1–deleted mice. Total
numbers of thymic B cells or DN 1 (lineage negative, CD1174425),
DN 2 (CD1174425), and DN 3 (CD1174425) thymocytes from
Notch 1 adult deleted mice (at various times after deletion) were normal-
ized to the equivalent subset from pIpC-treated control mice which was
taken as 100%. Data are mean values of 8–12 mice per time point.
Figure 3. Mature phenotype of circulating B cells in Notch1/
mice. (A) Expression of B220 versus IgM on PBLs isolated from pIpC-
treated control or Notch 1–deficient mice on days 7, 14, 21, and 28 after
deletion. (B) Expression of IgM, IgD, class II, AA4.1, BP-1, and CD43
on gated B220CD19 B cells isolated from PBLs from control (dotted
line) compared with Notch 1 deleted (solid line) 21 d after deletion.
Data for each part of Fig. 3 are representative FACS® profiles from ex-
periments in which six mice of each genotype were analyzed at each
time point.
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thymus after intrathymic reconstitution. In agreement with
previous reports, immature CD4CD8 double-positive
(DP) and mature CD4 single-positive (SP) and CD8 SP
cells of donor origin are observed in the thymus injected
with control BM cells (23). The distribution of these sub-
sets is skewed toward DP and mature SP thymocyte subsets
(Fig. 5 B) with few, if any immature DN, and no CD25
thymic precursors (data not shown), consistent with the
fact that intrathymic injection of total BM gives rise to a
single wave of reconstitution rather than permanent recon-
stitution as is the case with normal BM seeding. In contrast,
no CD4- or CD8-expressing cells are produced in the thy-
mus after intrathymic injection of Notch 1–deficient BM
(Fig. 5 B). Instead, these CD45.2 Notch 1–deficient BM
precursors give rise to immature B cells expressing CD19,
B220, and AA4.1 (Fig. 5 C), as observed in adult deleted
thymus, whereas CD45.2 control donor-derived BM did
not. Although the absolute number of donor-derived con-
trol or Notch 1–deficient cells was quite variable after in-
trathymic reconstitution the percentage of B cells in the
thymus was very reproducible (0.4  0.5 versus 91  8 for
control and Notch 1/ BM, respectively). These data
demonstrate that Notch 1/ BM precursors adopt a B (but
not T) cell fate upon intrathymic transfer and thus imply
that the immature B cells seen in the thymus of adult de-
leted (or chimeric) mice are the progeny of Notch 1–defi-
cient common lymphoid precursors (CLPs) that have mi-
grated to the thymus.
Notch 1–deficient Thymic B Cells Do Not Resemble Thymic
B Cells Detected in Other T Cell–deficient Mouse Models. A
small number of B cells have previously been detected in
the normal thymus (16). However, the phenotype of these
B cells is predominantly that of mature or activated cells
and the number is extremely small (around 0.24  0.13 	
106 per thymus). In addition, in at least two T cell–defi-
cient mouse models (TCR/ and CD326 tg), increased
numbers of B cells have been described in the thymus (17,
20). To eliminate the possibility that Notch 1–deficient
thymic B cells only accumulate due to a relative lack of
normal T cell development, we have compared the num-
ber and phenotype of thymic B cells in adult Notch 1–deleted
mice with those found in the thymus of either TCR/
or CD326tg mice. As shown in Fig. 6, the thymus of
Notch 1–deficient mice contains 
10-fold more B cells
than age-matched TCR/ or CD326tg mice. More-
over the majority of thymic B cells in both TCR/ or
CD326tg mice are mature IgM BP-1, AA4.1 CD19
B220 B cells, while those found in the Notch 1–deleted
thymus express heterogeneous levels of IgM, BP-1, and
AA4.1 (Fig. 6).
Localization of Notch 1–deficient Thymic B Cells to the Thy-
mus Medulla. Immunohistochemical analysis of frozen
sections of thymi of mixed BM chimeras (Fig. 7) show
that CD45.2 cells derived from control BM are spread
throughout the thymus cortex and medulla consistent
with their comprising all immature and mature thymus
Figure 4. Rapid turnover of
Notch1/ thymic B cells. Per-
centage of BrdU B cells (gated
as B220CD19) from thymus,
PBLs, spleen, and BM isolated
from control (right panel) or
Notch 1–deleted (14 d after de-
letion, left panel) mice after 12,
24, or 48 h continuous labeling.
Data are mean  SD of 4–8
mice per time point.
Figure 5. Notch1/ BM cells give rise to B cells upon
intrathymic injection. (A) Expression of CD45.2 (donor
derived) versus CD45.1 (host derived) in the thymus 21 d
after intrathymic injection of control (top panel) or Notch
1–deficient (bottom panel) BM. Contour plots contain
around 500,000 events. (B) Expression of CD4 versus
CD8 in CD45.2 (donor derived) thymocytes 21 d after
intrathymic injection of control (top) or Notch 1–deleted
(bottom) BM. Contour plots contain around 10,000 and
5,000 events, respectively. (C) Expression of B220, CD19,
and AA4.1 on CD45.2CD4CD8 (donor derived) thy-
mocytes 21 d after intrathymic injection of Notch 1–deleted
BM. Data for all parts of Fig. 5 are representative stainings
from three independent experiments.
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subsets. In contrast, all CD45.2 cells derived from Notch
1–deficient BM are found localized in clusters throughout
the medulla, and none are detectable in the cortex or
outer cortical regions. As expected, staining of serial sec-
tions with a B cell–specific antibody (B220) shows that
virtually all the CD45.2 cells from Notch 1–deficient
BM are indeed B cells. Thus similar to the normal resident
thymic B cell population (14, 15), immature Notch 1/
thymic B cells are localized to the thymic medulla and
corticomedullary region.
Discussion
We have previously shown that in the absence of Notch
1 signaling in BM precursors, no T cells are produced ei-
ther in the thymus or extrathymically in the gut (9, 11). At
the same time, a heterogeneous population of B cells is ob-
served accumulating in the thymus (9). One interpretation
of these data is that a Notch 1–deficient CLP adopts a B
cell fate instead of a T cell fate in the thymus. This hypoth-
esis is in agreement with the previously well established
function of Notch family genes in invertebrate bipotential
cell fate decisions (1, 26, 27). However, an alternative pos-
sibility that cannot be excluded is that Notch 1–deficient
precursors are unable to home from the BM to the thymus
and consequently can no longer give rise to mature T cells.
If this were the case, the existence of a heterogeneous B
cell population in the thymus could be the result of differ-
ent scenarios which may or may not be dependent on
Notch 1 deficiency in BM precursors, such as recirculation
of BM B cells via the blood to the thymus (17) or en-
hanced development of resident thymic B cell precursors as
a consequence of increased availability of thymic niches in
the absence of normal T cell development and expansion
(17, 20).
Figure 6. Comparison of thymic B cells in Notch1/ versus other T
cell–deficient mouse models. Number and phenotype of thymic B cells in
(A) control, (B) day 28 adult Notch 1 deleted, (C) CD326tg, and (D)
TCR-deficient mice. CD19 versus B220 profiles on total thymus (left
panels), expression of IgM (middle panels), and BP-1 versus AA4.1 (right
panels) on gated B220 B cells. The numbers are mean  SD of total B
cells (	106) per thymus from 7–10 mice of each genotype.
Figure 7. Tissue localization of intrathymic Notch1/ B cells in
mixed BM chimeras. Expression of CD45.2 (top two panels) and B220
(bottom panel) on serial sections of thymi reconstituted with control (top
panel) or Notch 1 deleted (bottom panels) BM precursors.
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Our results to date demonstrating a strict requirement for
Notch 1 in T cell development have been obtained using a
competitive mixed BM chimera system. As inducible dele-
tion of Notch 1 is close to 100% in the BM, this system
provides an ideal model to evaluate the capacity of BM
precursor cells to regenerate all hematopoietic lineages (9).
However, BM chimeras are not optimal to address such
questions as kinetics and population turnover, as these pop-
ulations may be influenced by the altered environment of
the irradiated host. Therefore, we have developed an alter-
native model in which Notch 1 is inducibly deleted in the
BM of adult mice and the thymus analyzed at various time
points after deletion. As the thymus is continually seeded
from BM precursors during adult life the complete turn-
over of all populations of thymocytes occurs roughly once
every 3–4 wk (23, 24, 28–31). In this way it is possible to
follow the loss (or appearance) of defined intrathymic pop-
ulations in a sequential manner if there is a complete block
in the influx of BM CLPs to the thymus, or if those that do
enter are unable to differentiate further along the T cell de-
velopmental pathway. Moreover, if a CLP adopts a default
cell fate in the thymus, it should be possible to follow the
kinetics of appearance of cells belonging to the default
pathway. The thymic phenotype obtained in the Notch 1
adult deletion model resembles that already described in the
mixed BM chimeras with respect to inhibition of T cell de-
velopment, as well as the phenotype and accumulation of
thymic B cells (9). However, the block in T cell develop-
ment is less complete in adult Notch 1–deleted mice than
in BM chimeras. The residual T cells present in adult de-
leted mice presumably remain either because their intrathy-
mic precursors have not undergone Notch 1 deletion
(which is much less efficient in the thymus than the BM) or
due to the fact that their further development and/or mat-
uration is no longer Notch 1 dependent. In the latter con-
text we have recently shown that deletion of Notch 1 at
the CD25 DN stage (using a Cre-recombinase transgene
driven by a CD4 minigene promoter) does not detectably
influence subsequent thymus development (32).
Notch 1–deficient thymic B cells can be first detected as
a distinct population expressing lower levels of both CD19
and B220 (compared with resident B cells) around 7 d after
deletion. Subsequently, their number increases to around
2–6 	 106 at 28 d. This accumulating population of B cells
expresses several markers specific for immature B cells, such
as BP-1, AA4.1, and CD25, is predominantly negative for
mature B cell markers such as Sca-1, IgD, and class II, and
is heterogeneous for IgM. This phenotypic analysis of
Notch 1/ thymic B cells clearly identifies cells resem-
bling all stages of BM B cell development up until surface
expression of IgD (33–36), and is consistent with de novo
ectopic B cell development in the thymus. This is in stark
contrast to the small population of resident thymic B cells
that can be isolated from normal thymus and which is pre-
dominantly composed of CD19hi, B220hi, IgM, IgD,
Sca-1, AA4.1, BP-1, CD25 cells (14). Although puta-
tive B cell precursors have been described in normal thy-
mus (16, 17), their phenotype is different to that observed
in the adult deleted Notch 1–deficient thymus (16), and
their absolute number is 10-fold less.
One simple explanation for the appearance of immature
Notch 1–deficient B cells in the thymus is that there is an
influx of recirculating BM B cells after pIpC induction of
IFN- (which is required to mediate Cre-recombinase de-
letion). If this were the case, one might expect to see im-
mature B cells in the blood of both Notch 1–deficient and
control mice, and perhaps immature B cells in the thymus
of control mice as well. However, between 2 and 28 d af-
ter pIpC treatment no immature phenotype B cells have
been observed in the blood of either Notch 1–deficient or
control mice.
Another possibility is that whenever T cell development
is severely impaired in the thymus, an increase in thymic B
cells can be observed, perhaps due to an increase in the
number of niches available for precursor seeding (17, 20).
In the wild-type thymus the presence of normal numbers
of T cells would exert an inhibitory effect on thymic B cell
development. If this is the case, one could expect to find an
increase in thymic B cells in all mouse models in which T
cell (but not B cell) development is impaired at an early
stage. Moreover, the developmental status and phenotype
of those B cells should be comparable to those developing
from Notch 1–deficient precursors. However, in the only
two models in which such an increase in thymic B cells has
been reported, the phenotype observed is essentially that of
mature B cells, and the relative increase in B cell numbers is
much less than in the Notch 1–deficient thymus (17, 20).
Furthermore, the similar heterogeneous immature pheno-
type and dramatic increase in number of thymic B cells ob-
served in Notch 1/ mixed BM chimeras, where the
overall size of the thymus is normal (9), rules out an impor-
tant role for availability of “niches” in ectopic B cell devel-
opment in the thymus.
A unique advantage of the adult Notch 1 deletion model
is that it permits analysis of the kinetics of loss of intrathy-
mic T cell precursor subsets expressing CD117 and/or
CD25 (DN 1, 2, and 3). The timing of this progressive de-
crease of T cell precursors confirms and extends previous
studies using [3H]thymidine uptake (28–30, 37, 38) and
BrdU uptake (31), which have defined the time taken for a
BM precursor to differentiate into a DP and subsequently
SP mature thymocyte. Although no precursor/product
studies have been performed, the kinetics of loss of T cell
precursors and simultaneous accumulation of immature B
cells are consistent with a model in which immature Notch
1–deficient B cells develop from CLP in the thymus as the
default cell fate in the absence of Notch 1 signaling.
More direct evidence for the hypothesis that Notch
1–deficient thymic B cells arise in situ comes from a ki-
netic analysis of BrdU uptake. In comparison to mature,
peripheral B cells, (or indeed, normal resident thymic B
cells) Notch 1–deficient thymic B cells have a 10-fold
faster rate of BrdU labeling. Indeed, the labeling kinetics of
Notch 1–deficient thymic B cells is almost identical to that
of BM B cells, strongly suggesting that they mature ectopi-
cally in the thymus.
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Perhaps the most compelling argument that Notch 1 sig-
naling controls the fate of bipotent T/B precursors in the
thymus is provided by intrathymic reconstitution studies.
Whereas (as expected) control BM precursors give rise ex-
clusively to T lineage cells after intrathymic transfer, Notch
1/ BM precursors only give rise to immature B cells,
with a phenotype indistinguishable from those seen in adult
Notch 1–deleted mice. The complete absence of T cell re-
constitution after intrathymic transfer of Notch 1/ BM
precursors formally demonstrates that defective thymic
homing of CLP per se cannot account for the block in T
cell development in Notch 1–deficient mice. Furthermore,
the efficient generation of immature B cells from intrathy-
mic transferred Notch 1/ BM shows that a Notch 1–defi-
cient precursor (most likely a CLP) can progress along an
ectopic B cell developmental pathway in the thymus.
Taken together, our data strongly support the hypothesis
that Notch 1–deficient CLPs which are unable to continue
along the T cell developmental program due to the absence
of Notch 1 signals, take the default cell fate decision, and
undergo de novo B cell development in the thymus.
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